OXYNORM

This brand name is authorized in Australia, Austria, Brazil, Cyprus, Finland, France, Hong Kong SAR China, Ireland, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug OXYNORM contains one active pharmaceutical ingredient (API):

1	Oxycodone UNII C1ENJ2TE6C - OXYCODONE HYDROCHLORIDE
	Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative.
	Read more about Oxycodone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OXYNORM Capsule, hard	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
OXYNORM Concentrate oral solution	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
OXYNORM 10 mg/ml Solution for injection or infusion	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AA05	Oxycodone	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	12031F, 12074L, 12311Y, 12314D, 5190E, 5191F, 5197M, 8464L, 8501K, 8502L, 8644Y
BR	Câmara de Regulação do Mercado de Medicamentos	556721030004905, 556721030005005
ES	Centro de información online de medicamentos de la AEMPS	66574, 66575, 66576, 66614, 71243
FI	Lääkealan turvallisuus- ja kehittämiskeskus	003449, 003485, 004795, 005068, 005088, 006244, 006255, 006263, 022119
FR	Base de données publique des médicaments	60209645, 60629186, 61007415, 61115864, 61613434, 65821685, 66268312, 67565715, 68127381
GB	Medicines & Healthcare Products Regulatory Agency	155455, 162207, 162209, 162211, 186052, 186054, 28958, 28961, 28964, 28976, 28984, 376967, 376969, 376971, 381590, 46355, 46361
HK	Department of Health Drug Office	59575, 59576, 59577, 61835, 66357, 66358
IE	Health Products Regulatory Authority	38149, 38162, 38174, 38196, 38239, 38546, 38710, 59007, 59017, 59024, 59073
NL	Z-Index G-Standaard	14903547, 14930978
NL	Z-Index G-Standaard, PRK	68209, 68217, 68225, 70726, 72761, 94374, 94390, 94412
NZ	Medicines and Medical Devices Safety Authority	11876, 12258, 13456, 9550, 9551, 9552
PL	Rejestru Produktów Leczniczych	100206840
SG	Health Sciences Authority	13079P, 13081P, 13083P, 13733P, 14125P, 14126P
TN	Direction de la Pharmacie et du Médicament	16263021, 16263022, 16263023
ZA	Health Products Regulatory Authority	41/2.9/1103, 41/2.9/1104, 41/2.9/1105, 46/2.9/0718, 46/2.9/0719